The STAT3 mutation frequency was not different in the cohorts of T-LGL leukemia with and without SS, totaling 57% (12 of 21 patients) in the cohort of patients with SS and 60% (27 of 45 patients) in the cohort with RD but without SS (p = 1). The gene discussed is STAT3; the disease is synovial sarcoma.